Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole vs esomeprazole injection for nonvariceal upper gastrointestinal bleeding (real-world noninferiority)
ChiCTR2300073453Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ilaprazole in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoints: Prevention success rate, Hemostatic effective rate and 1 more. Started Jul 2023; status: completed.
02
Drugs
ilaprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on ChiCTR2300073453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073453.